Could high FSH in women indicate menopause or ovarian failure?

High FSH levels in women often signal declining ovarian function, indicating either approaching menopause or premature ovarian insufficiency. FSH levels above 25-40 mIU/mL measured twice suggest diminished ovarian reserve, requiring evaluation with other hormones for accurate diagnosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

If you've recently had blood work done and noticed your follicle-stimulating hormone (FSH) levels are elevated, you might be wondering what this means for your reproductive health. FSH is a crucial hormone that plays a central role in female fertility and the menstrual cycle, and changes in its levels can provide important insights into ovarian function.

High FSH levels in women can indeed indicate approaching menopause or ovarian insufficiency, but the interpretation depends on several factors including your age, symptoms, and other hormone levels. Understanding what FSH does and why it rises can help you make sense of your test results and work with your healthcare provider to determine the best path forward.

Understanding FSH and Its Role in Female Reproduction

Follicle-stimulating hormone is produced by the pituitary gland in your brain and serves as a key messenger in the reproductive system. In women, FSH stimulates the growth and development of ovarian follicles, which contain the eggs. During each menstrual cycle, FSH levels rise to trigger follicle development, then fall as estrogen levels increase.

FSH Levels Throughout a Woman's Life

FSH levels should be measured on cycle days 2-5 for accurate assessment of ovarian reserve.
Life StageTypical FSH Range (mIU/mL)Clinical Significance
Follicular phase (reproductive years)Follicular phase (reproductive years)3-10Normal ovarian function
Midcycle peakMidcycle peak4-25LH surge and ovulation
Luteal phaseLuteal phase1-9Post-ovulation
PerimenopausePerimenopause10-40 (variable)Declining ovarian reserve
PostmenopausePostmenopause>40Cessation of ovarian function
POI (under 40)POI (under 40)>25-40Premature ovarian insufficiency

FSH levels should be measured on cycle days 2-5 for accurate assessment of ovarian reserve.

This delicate hormonal dance relies on feedback loops between the brain and ovaries. When the ovaries are functioning well and producing adequate estrogen, they signal the pituitary to reduce FSH production. However, when ovarian function declines and estrogen production drops, the pituitary responds by producing more FSH in an attempt to stimulate the ovaries - similar to pressing harder on the gas pedal when your car is running out of fuel.

The FSH-Estrogen Feedback Loop

The relationship between FSH and estrogen is inverse - as one goes up, the other typically goes down. This negative feedback loop maintains hormonal balance throughout the reproductive years. When ovarian reserve (the number and quality of remaining eggs) decreases, the ovaries become less responsive to FSH stimulation, leading to:

  • Reduced estrogen production
  • Increased FSH levels as the pituitary tries to compensate
  • Irregular or absent menstrual cycles
  • Various menopausal symptoms

Normal vs. High FSH Levels in Women

FSH levels naturally fluctuate throughout the menstrual cycle and change significantly across a woman's lifespan. Understanding what constitutes a normal versus elevated FSH level requires considering both the timing of the test and your age.

When to Test FSH

For the most accurate assessment of ovarian reserve, FSH should be measured on day 2-5 of your menstrual cycle (with day 1 being the first day of full menstrual flow). This is when FSH levels are at their baseline and provide the clearest picture of ovarian function. Testing at other times in the cycle can yield misleading results.

If you're no longer having regular periods, FSH can be tested at any time, though your healthcare provider may recommend multiple tests to confirm consistently elevated levels. The diagnosis of menopause or ovarian insufficiency typically requires two FSH readings above 25-40 mIU/mL taken at least one month apart.

High FSH and Menopause

Menopause, defined as 12 consecutive months without a menstrual period, typically occurs between ages 45-55, with the average age being 51. During the transition to menopause (perimenopause), FSH levels begin to rise as ovarian function gradually declines. This process can take several years and is characterized by fluctuating hormone levels and irregular cycles.

Stages of Reproductive Aging

The Stages of Reproductive Aging Workshop (STRAW) criteria help classify where a woman is in her reproductive journey based on menstrual patterns and FSH levels:

  • Late reproductive stage: Regular cycles with slightly elevated FSH (>10 mIU/mL)
  • Early menopausal transition: Variable cycle length with FSH 10-25 mIU/mL
  • Late menopausal transition: Skipped cycles with FSH >25 mIU/mL
  • Postmenopause: No periods for 12+ months with FSH >40 mIU/mL

During perimenopause, FSH levels can fluctuate dramatically from month to month, which is why a single elevated reading doesn't necessarily confirm menopause. Some women may have an FSH of 50 mIU/mL one month and 15 mIU/mL the next, reflecting the erratic nature of ovarian function during this transition.

Premature Ovarian Insufficiency (POI)

When high FSH levels occur in women under 40, it may indicate premature ovarian insufficiency (POI), previously called premature ovarian failure. POI affects approximately 1% of women under 40 and 0.1% of women under 30. Unlike natural menopause, POI represents a loss of normal ovarian function at an unexpectedly young age.

Causes of POI

POI can result from various factors, though in many cases the cause remains unknown (idiopathic). Identified causes include:

  • Genetic conditions (Turner syndrome, Fragile X premutation)
  • Autoimmune disorders affecting the ovaries
  • Chemotherapy or radiation therapy
  • Surgical removal of ovaries
  • Certain infections (mumps, tuberculosis)
  • Environmental toxins
  • Family history of early menopause

Unlike menopause, women with POI may still have intermittent ovarian function. About 5-10% of women with POI conceive naturally, and up to 20% may have occasional menstrual periods. This unpredictability makes POI particularly challenging emotionally and requires specialized management. Regular hormone testing can help track ovarian function and guide treatment decisions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Symptoms Associated with High FSH

Whether due to natural menopause or POI, high FSH levels and the associated estrogen deficiency can cause a range of symptoms that significantly impact quality of life. These symptoms result from estrogen receptors throughout the body being deprived of adequate hormone stimulation.

Managing Symptoms

The severity and combination of symptoms vary greatly among women. Some experience minimal disruption to their daily lives, while others find the symptoms debilitating. Tracking your symptoms alongside hormone levels can help you and your healthcare provider develop an effective management strategy. Many women find that symptoms fluctuate with hormone levels, particularly during perimenopause when levels are most erratic.

Diagnostic Approach to High FSH

Diagnosing the cause of high FSH requires a comprehensive approach that goes beyond a single blood test. Your healthcare provider will consider your age, symptoms, menstrual history, and other hormone levels to determine whether you're experiencing natural menopause, POI, or another condition affecting ovarian function.

Additional Tests Often Ordered

To get a complete picture of your hormonal status and rule out other conditions, your provider may order:

  • Estradiol levels to assess current ovarian estrogen production
  • Anti-Müllerian hormone (AMH) to evaluate ovarian reserve
  • Luteinizing hormone (LH) which typically rises along with FSH
  • Thyroid function tests (TSH, Free T4) to rule out thyroid disorders
  • Prolactin to exclude pituitary problems
  • Testosterone and DHEA-S to assess androgen levels
  • Chromosome analysis if POI is suspected in young women

For women under 40 with elevated FSH, additional testing may include screening for autoimmune conditions, genetic testing for Fragile X premutation, and pelvic ultrasound to visualize the ovaries. A comprehensive hormone panel can provide valuable insights into your overall reproductive health and help guide treatment decisions.

Treatment Options and Management Strategies

The approach to managing high FSH depends on your age, symptoms, and reproductive goals. While FSH levels themselves cannot be lowered in cases of true ovarian insufficiency, the symptoms and health risks associated with estrogen deficiency can be effectively managed through various interventions.

Hormone Therapy Considerations

For women with POI, hormone therapy is typically recommended until the natural age of menopause (around 51) to protect bone health, cardiovascular function, and cognitive health. This differs from hormone therapy in older menopausal women, as younger women need hormone replacement to achieve normal premenopausal hormone levels rather than treating symptoms alone.

Hormone therapy options include:

  • Estrogen therapy (oral, transdermal patch, or vaginal)
  • Progesterone (if you have a uterus) to protect against endometrial cancer
  • Combination hormone therapy
  • Bioidentical hormone preparations
  • Low-dose birth control pills for perimenopausal women

Lifestyle Modifications

Regardless of whether you choose hormone therapy, certain lifestyle changes can help manage symptoms and protect long-term health:

  • Regular weight-bearing exercise to maintain bone density
  • Calcium and vitamin D supplementation
  • Heart-healthy diet rich in phytoestrogens
  • Stress management techniques
  • Adequate sleep hygiene
  • Limiting alcohol and caffeine
  • Smoking cessation

Fertility Considerations with High FSH

For women who still hope to conceive, high FSH levels present unique challenges but don't always mean pregnancy is impossible. The approach depends on whether ovarian function is completely absent or intermittent, and whether any eggs remain that could potentially be stimulated.

Women with high FSH who wish to conceive should work with a reproductive endocrinologist to explore options such as:

  • Aggressive ovarian stimulation protocols
  • Use of donor eggs
  • Embryo donation
  • Adoption
  • Experimental treatments to improve ovarian function

Some women with POI experience spontaneous pregnancies during periods of intermittent ovarian function, though this is unpredictable. Regular monitoring of hormone levels can help identify windows of potential fertility.

Long-term Health Implications

Whether due to natural menopause or POI, the estrogen deficiency associated with high FSH has important long-term health implications that extend beyond reproductive concerns. Understanding these risks allows for proactive management and prevention strategies.

Key health concerns include:

  • Osteoporosis and increased fracture risk
  • Cardiovascular disease
  • Cognitive changes and potential dementia risk
  • Vaginal and urinary health issues
  • Sexual dysfunction
  • Mood disorders
  • Metabolic changes and weight gain

Women with POI face these risks at a younger age, making prevention strategies particularly important. Regular health screenings, including bone density scans, cardiovascular assessments, and metabolic panels, help monitor for complications and guide preventive interventions.

Moving Forward with High FSH

Discovering you have high FSH levels can be emotionally challenging, particularly if you're young or hoping to expand your family. However, understanding what these levels mean and working with knowledgeable healthcare providers can help you navigate this transition and maintain optimal health.

Remember that FSH is just one piece of the puzzle. A comprehensive evaluation including multiple hormones, symptoms, and health goals provides the best foundation for developing an individualized treatment plan. Whether you're experiencing natural menopause or dealing with POI, numerous resources and treatment options are available to help you maintain quality of life and protect your long-term health.

Regular monitoring of your hormone levels can help track changes over time and adjust treatment as needed. Many women find that understanding their hormonal patterns empowers them to make informed decisions about their health and advocate effectively for their needs in medical settings.

References

  1. Practice Committee of the American Society for Reproductive Medicine. (2020). Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility, 114(6), 1151-1157.[PubMed][DOI]
  2. European Society of Human Reproduction and Embryology (ESHRE) Guideline Group on POI. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction, 31(5), 926-937.[PubMed][DOI]
  3. Harlow, S. D., Gass, M., Hall, J. E., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. The Journal of Clinical Endocrinology & Metabolism, 97(4), 1159-1168.[PubMed][DOI]
  4. Nelson, L. M. (2009). Primary ovarian insufficiency. New England Journal of Medicine, 360(6), 606-614.[PubMed][DOI]
  5. Santoro, N., & Randolph, J. F. Jr. (2011). Reproductive hormones and the menopause transition. Obstetrics and Gynecology Clinics of North America, 38(3), 455-466.[PubMed][DOI]
  6. Webber, L., Davies, M., Anderson, R., et al. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction, 31(5), 926-937.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my FSH at home?

You can test your FSH at home with SiPhox Health's Hormone Focus Program or the Women's Essential Hormone Panel. Both CLIA-certified programs include FSH testing along with other key reproductive hormones, providing lab-quality results from the comfort of your home.

What FSH level indicates menopause?

An FSH level consistently above 40 mIU/mL, measured on two occasions at least one month apart, typically indicates menopause. However, during perimenopause, FSH levels can fluctuate significantly, so a single elevated reading doesn't confirm menopause. Levels between 25-40 mIU/mL suggest diminished ovarian reserve.

Can high FSH levels return to normal?

In true menopause or established POI, FSH levels generally remain elevated. However, during perimenopause, FSH can fluctuate dramatically and may temporarily return to normal ranges. Some women with POI experience intermittent ovarian function with temporary FSH normalization, though this is unpredictable.

What's the difference between high FSH in POI versus menopause?

The main difference is age of onset - POI occurs before age 40 while natural menopause typically occurs around age 51. Women with POI may have intermittent ovarian function and can occasionally ovulate or menstruate, while menopause represents permanent cessation of ovarian function. POI also carries greater long-term health risks due to prolonged estrogen deficiency.

Should I test other hormones along with FSH?

Yes, testing FSH alone provides limited information. A comprehensive hormone panel including estradiol, LH, AMH, and thyroid hormones gives a more complete picture of your reproductive health. Additional tests like prolactin, testosterone, and DHEA-S can help rule out other conditions affecting your hormones.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details